The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Loey Dietz Syndrome Foundation
PO Box 22468
Baltimore, MD 21203
Loey Dietz Syndrome Foundation (LDSF) is a voluntary organization whose mission is to encourage the education of medical professionals and lay communities about Loey Dietz syndrome (LDS) in order to aid in the identification, diagnosis, and treatment of this disorder. LDSF also fosters research on LDS and provides a support network for those impacted by it. Loeys-Dietz syndrome is a genetic disorder of connective tissue caused by a mutation in either of the two genes that tell the body how to make proteins called transforming growth factor beta receptor 1 (TGFBR1) and transforming growth factor beta receptor 2 (TGFBR2.) Because connective tissue is found throughout the body, LDS features can occur in the musculoskeletal, skin and cardiovascular systems.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.